Reyataz and Deafness neurosensory - from FDA reports
There is no Deafness neurosensory reported by people who take Reyataz yet. This review analyzes which people have Deafness neurosensory with Reyataz. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Dec, 16, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Deafness neurosensory when taking Reyataz?
- Check symptoms - is deafness neurosensory caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- write a review - share your experience related to the study
- More tools...
Expand the study to include all drugs with the same ingredientsDeafness neurosensory and drugs with ingredients of atazanavir sulfate.
Expand the study to include reports from both FDA and eHealthMeDeafness neurosensory and Reyataz from FDA and eHealthMe reports
Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. (latest outcomes from Reyataz 8,724 users)
Deafness neurosensory has been reported by people with osteoporosis, osteopenia, depression, high blood pressure, rheumatoid arthritis (latest reports from 2,551 Deafness neurosensory patients).